scispace - formally typeset
P

Peter G. Schultz

Researcher at Scripps Research Institute

Publications -  901
Citations -  96321

Peter G. Schultz is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Amino acid & Transfer RNA. The author has an hindex of 156, co-authored 893 publications receiving 89716 citations. Previous affiliations of Peter G. Schultz include Novartis Foundation & University of California, Berkeley.

Papers
More filters
Journal ArticleDOI

A New Strategy for the Synthesis of Glycoproteins

TL;DR: An approach to the cotranslational synthesis of selectively glycosylated proteins in which the modified amino acid is genetically encoded is reported, showing that myoglobin containing β–N-acetylglucosamine–serine at a defined position can be expressed in Escherichia coli in good yield and with high fidelity.
Journal ArticleDOI

A genetically encoded fluorescent probe in mammalian cells

TL;DR: The small size of Anap, its environment-sensitive fluorescence, and the ability to introduce Anap at specific sites in the proteome by simple mutagenesis make it a unique and valuable tool in eukaryotic cell biology.
Journal ArticleDOI

A New Functional Suppressor tRNA/ Aminoacyl-tRNA Synthetase Pair for the in Vivo Incorporation of Unnatural Amino Acids into Proteins

TL;DR: This approach involves the generation of a suppressor tRNA/aminoacyl-tRNA synthetase (tRNACUA/aaRS) pair that is orthogonal to Escherichia coli endogenous tRNAs and insights into the development of additional pairs are provided.
Journal ArticleDOI

Enthalpy arrays

TL;DR: The utility of the enthalpy arrays is demonstrated by showing measurements for two protein-ligand binding interactions, phosphorylation of glucose by hexokinase, and respiration of mitochondria in the presence of 2,4-dinitrophenol uncoupler.
Journal ArticleDOI

Synthesis of bispecific antibodies using genetically encoded unnatural amino acids.

TL;DR: An anti-HER2/anti-CD3 bispecific antibody is synthesized, which efficiently cross-linked HER2+ cells and CD3+ cells, and in vitro effector-cell mediated cytotoxicity was observed at picomolar concentrations.